Einzelnachweise

  1. ↑ Hauser SL et al. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N Engl J Med 2008; 358:676-88.
  2. ↑ Ehrenreich H et al. Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis. Brain 2007; 130:2577-88.
  3. ↑ Garren H et al. and the BHT-3900 Study Group. Phase 2 trial of a DNA vaccine encoding myelin basic proteine for multiple sclerosis Ann Neurol 2008; 63:611-20.
  4. ↑ Vollmer T et al. Oral simvastatin treatment in relapsing-remitting multiple sclerosis. Lancet 2004; 363:1607-8.
  5. ↑ Paul F et al. Oral high-dose atorvastatin treatment in relapsing-remitting multiple sclerosis. PLoS ONE 2008; 3(4):e1928.